2016
DOI: 10.1038/srep38813
|View full text |Cite
|
Sign up to set email alerts
|

Liver Enzymes and Risk of Ischemic Heart Disease and Type 2 Diabetes Mellitus: A Mendelian Randomization Study

Abstract: We used Mendelian randomization to estimate the causal effects of the liver enzymes, alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT), on diabetes and cardiovascular disease, using genetic variants predicting these liver enzymes at genome wide significance applied to extensively genotyped case-control studies of diabetes (DIAGRAM) and coronary artery disease (CAD)/myocardial infarction (MI) (CARDIoGRAMplusC4D 1000 Genomes). Genetically higher ALT was associated wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
36
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 50 publications
(41 citation statements)
references
References 50 publications
4
36
0
Order By: Relevance
“…In addition to the suggested genetic correlations in Europeans (type 2 diabetes and BMI; triglycerides, blood sugar, and hemoglobin A1c; coronary artery disease and BMI; and high-density-lipoprotein cholesterol and triglycerides) 15 , we empirically corroborated novel genetic correlations that have been implicated in Mendelian randomization analyses (e.g., type 2 diabetes and alanine aminotransferase 31 ; atrial fibrillation and height 32 ; asthma and eosinophil count 9 ; and colorectal cancer and height 33 ) and epidemiological studies (e.g., ischemic stroke and uric acid 34 ; myocardial infarction and albumin/globulin ratio 35 ; peripheral artery disease and total Tables 1 and 2. bilirubin 36 ; and urolithiasis and blood pressure 37 ) (Supplementary Table 8). Thus, we further investigated causal relationships between the significant pairs of quantitative traits and diseases by using a Mendelian randomization approach (Methods).…”
Section: And Supplementarysupporting
confidence: 65%
“…In addition to the suggested genetic correlations in Europeans (type 2 diabetes and BMI; triglycerides, blood sugar, and hemoglobin A1c; coronary artery disease and BMI; and high-density-lipoprotein cholesterol and triglycerides) 15 , we empirically corroborated novel genetic correlations that have been implicated in Mendelian randomization analyses (e.g., type 2 diabetes and alanine aminotransferase 31 ; atrial fibrillation and height 32 ; asthma and eosinophil count 9 ; and colorectal cancer and height 33 ) and epidemiological studies (e.g., ischemic stroke and uric acid 34 ; myocardial infarction and albumin/globulin ratio 35 ; peripheral artery disease and total Tables 1 and 2. bilirubin 36 ; and urolithiasis and blood pressure 37 ) (Supplementary Table 8). Thus, we further investigated causal relationships between the significant pairs of quantitative traits and diseases by using a Mendelian randomization approach (Methods).…”
Section: And Supplementarysupporting
confidence: 65%
“…[1] Mendelian randomization (MR) studies, taking advantage of the random allocation of genetic endowment at conception to obtain un-confounded estimates, [2] have clarified the role of liver function in T2DM. Specifically, these studies suggest that higher alanine aminotransferase (ALT) [3,4] or aspartate aminotransferase (AST) [4] rather than other measures of liver function, such as glutamyltransferase (GGT), [3,4] could play a role in T2DM. However, modifiable targets on the pathway from poor liver function to T2DM are unclear and worthy of exploration.…”
Section: Introductionmentioning
confidence: 99%
“…Abnormal serum ALT levels are found in a variety of liver diseases such as viral hepatitis, alcoholic liver disease, or nonalcoholic fatty liver disease (NAFLD). The risk of cardiovascular disease such as ischemic heart disease or type 2 diabetes mellitus also increases in the case of elevated ALT levels [4,5]. Furthermore, the risk of MS increases in participants with elevated ALT levels [6,7].…”
Section: Introductionmentioning
confidence: 99%